Proteomics, biomarkers, and HIV-1: A current perspective

Proteomics - Clinical Applications

Volumn 10, Issue 2, 2016, Pages 110-125

  Donnelly, Maire Rose ^a   Ciborowski, Pawel ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Biomarker; Body fluids; HIV; Macrophage; Systems biology; T cell

Indexed keywords

BIOLOGICAL MARKER; PROTEOME; VIRAL PROTEIN;

ARTICLE; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; GEL ELECTROPHORESIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOTOPE LABELING; MOLECULAR DYNAMICS; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEOMICS; SILAC METHOD; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; SWATH MS METHOD; SYSTEMS BIOLOGY; TANDEM MASS TAG; VIRUS IDENTIFICATION; DRUG EFFECTS; HIV INFECTIONS; METABOLISM; VIROLOGY;

BIOMARKERS; HIV INFECTIONS; HIV-1; HUMANS; PROTEOMICS; VIRAL PROTEINS;

EID: 84956789227     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201500002     Document Type: Article

References (99)

1. Ciborowski, P., Biomarkers of HIV-1-associated neurocognitive disorders: challenges of proteomic approaches. Biomark. Med. 2009, 3, 771-785.
2. Calabria, A. R., Shusta, E. V., Blood-brain barrier genomics and proteomics: elucidating phenotype, identifying disease targets and enabling brain drug delivery. Drug Discov. Today 2006, 11, 792-799.
3. Simpson, R. J., Lim, J. W., Moritz, R. L., Mathivanan, S., Exosomes: proteomic insights and diagnostic potential. Expert. Rev. Proteomics 2009, 6, 267-283.
4. Ciborowski, P., Gendelman, H. E., Human immunodeficiency virus-mononuclear phagocyte interactions: emerging avenues of biomarker discovery, modes of viral persistence and disease pathogenesis. Curr. HIV Res. 2006, 4, 279-291.
5. Zhang, L., Zhang, X., Ma, Q., Zhou, H., Host proteome research in HIV infection. Genomics Proteomics Bioinformatics 2010, 8, 1-9.
6. Center for Disease Control. Pneumocystis Pneumonia - Los Angeles. MMWR 1981, 30, 250-252.
7. Stein, D. R., Burgener, A., Ball, T. B., Proteomics as a novel HIV immune monitoring tool. Curr. Opin. HIV AIDS 2013, 8, 140-146.
8. Zak, D. E., Aderem, A., Overcoming limitations in the systems vaccinology approach: a pathway for accelerated HIV vaccine development. Curr. Opin. HIV AIDS 2012, 7, 58-63.
9. Haverland, N. A., Fox, H. S., Ciborowski, P., Quantitative proteomics by SWATH-MS reveals altered expression of nucleic acid binding and regulatory proteins in HIV-1-infected macrophages. J. Proteome Res. 2014, 13, 2109-2119.
10. Jaworski, E., Saifuddin, M., Sampey, G., Shafagati, N. et al., The use of Nanotrap particles technology in capturing HIV-1 virions and viral proteins from infected cells. PloS One 2014, 9, e96778.
11. Bhat, A., Dakna, M., Mischak, H., Integrating proteomics profiling data sets: a network perspective. Methods Mol. Biol. 2015, 1243, 237-253.
12. Liu, Y., Chance, M. R., Integrating phosphoproteomics in systems biology. Comput. Struct. Biotechnol. J. 2014, 10, 90-97.
13. Philp, A., Rowland, T., Perez-Schindler, J., Schenk, S., Understanding the acetylome: translating targeted proteomics into meaningful physiology. Am. J. Physiol. Cell Physiol. 2014, 307, C763-C773.
14. Hoopmann, M. R., Moritz, R. L., Current algorithmic solutions for peptide-based proteomics data generation and identification. Curr. Opin. Biotechnol. 2013, 24, 31-38.
15. Hutchens, T. W. a. Y., T.-T., New desorption strategies for the mass spectrometric analysis of macromolecules. Rapid Commun. Mass Spectrom. 1993, 7, 576-580.
16. Moon, Y. S., Park, E. S., Kim, T. O., Lee, H. S., Lee, S. E., SELDI-TOF MS-based discovery of a biomarker in Cucumis sativus seeds exposed to CuO nanoparticles. Environ. Toxicol. Pharmacol. 2014, 38, 922-931.
17. von Saltzwedel, H., Maraun, M., Scheu, S., Schaefer, I., Evidence for frozen-niche variation in a cosmopolitan parthenogenetic soil mite species (acari, oribatida). PloS One 2014, 9, e113268.
18. Baggerly, K. A., Morris, J. S., Coombes, K. R., Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments. Bioinformatics 2004, 20, 777-785.
19. Luo, X., Carlson, K. A., Wojna, V., Mayo, R. et al., Macrophage proteomic fingerprinting predicts HIV-1-associated cognitive impairment. Neurology 2003, 60, 1931-1937.
20. Sun, B., Rempel, H. C., Pulliam, L., Loss of macrophage-secreted lysozyme in HIV-1-associated dementia detected by SELDI-TOF mass spectrometry. Aids 2004, 18, 1009-1012.
21. Ratto-Kim, S., Chuenchitra, T., Pulliam, L., Paris, R. et al., Expression of monocyte markers in HIV-1 infected individuals with or without HIV associated dementia and normal controls in Bangkok Thailand. J. Neuroimmunol. 2008, 195, 100-107.
22. Toro-Nieves, D. M., Rodriguez, Y., Plaud, M., Ciborowski, P. et al., Proteomic analyses of monocyte-derived macrophages infected with human immunodeficiency virus type 1 primary isolates from Hispanic women with and without cognitive impairment. J. Neurovirol. 2009, 15, 36-50.
23. Wiederin, J., Rozek, W., Duan, F., Ciborowski, P., Biomarkers of HIV-1 associated dementia: proteomic investigation of sera. Proteome Sci. 2009, 7, 8.
24. Burgener, A., Profiling cervical lavage fluid by SELDI-TOF mass spectrometry. Methods Mol. Biol. 2012, 818, 143-152.
25. Laspiur, J. P., Anderson, E. R., Ciborowski, P., Wojna, V. et al., CSF proteomic fingerprints for HIV-associated cognitive impairment. J. Neuroimmunol. 2007, 192, 157-170.
26. Berger, J. R., Avison, M., Mootoor, Y., Beach, C., Cerebrospinal fluid proteomics and human immunodeficiency virus dementia: preliminary observations. J. Neurovirol. 2005, 11, 557-562.
27. Pottiez, G., Jagadish, T., Yu, F., Letendre, S. et al., Plasma proteomic profiling in HIV-1 infected methamphetamine abusers. PloS One 2012, 7, e31031.
28. Bosley, A., Marshall, H. N., Badralmaa, Y., Natarajan, V., A method of HIV-1 inactivation compatible with antibody-based depletion of abundant proteins from plasma. Proteomics Clin. Appl. 2008, 2, 904-907.
29. Rozek, W., Ricardo-Dukelow, M., Holloway, S., Gendelman, H. E. et al., Cerebrospinal fluid proteomic profiling of HIV-1-infected patients with cognitive impairment. J. Proteome Res. 2007, 6, 4189-4199.
30. Rozek, W., Horning, J., Anderson, J., Ciborowski, P., Sera proteomic biomarker profiling in HIV-1 infected subjects with cognitive impairment. Proteomics Clin. Appl. 2008, 2, 1498-1507.
31. Kim, S. S., Kim, M. H., Shin, B. K., Na, H. J. et al., Different isoforms of apolipoprotein AI present heterologous post-translational expression in HIV infected patients. J. Proteome Res. 2007, 6, 180-184.
32. Zhang, L., Jia, X., Zhang, X., Cao, J. et al., Alpha-1 antitrypsin variants in plasma from HIV-infected patients revealed by proteomic and glycoproteomic analysis. Electrophoresis 2010, 31, 3437-3445.
33. Ciborowski, P., Kadiu, I., Rozek, W., Smith, L. et al., Investigating the human immunodeficiency virus type 1-infected monocyte-derived macrophage secretome. Virology 2007, 363, 198-209.
34. Bregnard, C., Zamborlini, A., Leduc, M., Chafey, P. et al., Comparative proteomic analysis of HIV-1 particles reveals a role for Ezrin and EHD4 in the Nef-dependent increase of virus infectivity. J. Virol. 2013, 87, 3729-3740.
35. Yohannes, E., Ghosh, S. K., Jiang, B., McCormick, T. S. et al., Proteomic signatures of human oral epithelial cells in HIV-infected subjects. PloS One 2011, 6, e27816.
36. Kraft-Terry, S., Gerena, Y., Wojna, V., Plaud-Valentin, M. et al., Proteomic analyses of monocytes obtained from Hispanic women with HIV-associated dementia show depressed antioxidants. Proteomics Clin. Appl. 2010, 4, 706-714.
37. Zhou, L., Diefenbach, E., Crossett, B., Tran, S. L. et al., First evidence of overlaps between HIV-Associated Dementia (HAD) and non-viral neurodegenerative diseases: proteomic analysis of the frontal cortex from HIV+ patients with and without dementia. Mol. Neurodegener. 2010, 5, 27.
38. Kadiu, I., Wang, T., Schlautman, J. D., Dubrovsky, L. et al., HIV-1 transforms the monocyte plasma membrane proteome. Cell. Immunol. 2009, 258, 44-58.
39. Reynolds, J. L., Mahajan, S. D., Sykes, D. E., Schwartz, S. A., Nair, M. P., Proteomic analyses of methamphetamine (METH)-induced differential protein expression by immature dendritic cells (IDC). Biochim. Biophys. Acta 2007, 1774, 433-442.
40. Reynolds, J. L., Mahajan, S. D., Sykes, D., Nair, M. P., Heroin-induces differential protein expression by normal human astrocytes (NHA). Am. J. Infectious Dis. 2006, 2, 49-57.
41. Reynolds, J. L., Mahajan, S. D., Bindukumar, B., Sykes, D. et al., Proteomic analysis of the effects of cocaine on the enhancement of HIV-1 replication in normal human astrocytes (NHA). Brain Res. 2006, 1123, 226-236.
42. Coiras, M., Camafeita, E., Urena, T., Lopez, J. A. et al., Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression. Proteomics 2006, 6 (Suppl 1), S63-S73.
43. Pendyala, G., Trauger, S. A., Siuzdak, G., Fox, H. S., Quantitative plasma proteomic profiling identifies the vitamin E binding protein afamin as a potential pathogenic factor in SIV induced CNS disease. J. Proteome Res. 2010, 9, 352-358.
44. Van Raemdonck, G., Zegels, G., Coen, E., Vuylsteke, B. et al., Increased Serpin A5 levels in the cervicovaginal fluid of HIV-1 exposed seronegatives suggest that a subtle balance between serine proteases and their inhibitors may determine susceptibility to HIV-1 infection. Virology 2014, 458-459, 11-21.
45. Huang, X., Stone, D. K., Yu, F., Zeng, Y., Gendelman, H. E., Functional proteomic analysis for regulatory T cell surveillance of the HIV-1-infected macrophage. J. Proteome Res. 2010, 9, 6759-6773.
46. Navare, A. T., Sova, P., Purdy, D. E., Weiss, J. M. et al., Quantitative proteomic analysis of HIV-1 infected CD4+ T cells reveals an early host response in important biological pathways: protein synthesis, cell proliferation, and T-cell activation. Virology 2012, 429, 37-46.
47. Shetty, V., Jain, P., Nickens, Z., Sinnathamby, G. et al., Investigation of plasma biomarkers in HIV-1/HCV mono- and coinfected individuals by multiplex iTRAQ quantitative proteomics. Omics 2011, 15, 705-717.
48. Jarboui, M. A., Bidoia, C., Woods, E., Roe, B. et al., Nucleolar protein trafficking in response to HIV-1 Tat: rewiring the nucleolus. PloS One 2012, 7, e48702.
49. Barrero, C. A., Datta, P. K., Sen, S., Deshmane, S. et al., HIV-1 Vpr modulates macrophage metabolic pathways: a SILAC-based quantitative analysis. PloS One 2013, 8, e68376.
50. Kraft-Terry, S. D., Engebretsen, I. L., Bastola, D. K., Fox, H. S. et al., Pulsed stable isotope labeling of amino acids in cell culture uncovers the dynamic interactions between HIV-1 and the monocyte-derived macrophage. J. Proteome Res. 2011, 10, 2852-2862.
51. Wang, W., Zhou, H., Lin, H., Roy, S. et al., Quantification of proteins and metabolites by mass spectrometry without isotopic labeling or spiked standards. Anal. Chem. 2003, 75, 4818-4826.
52. Schweitzer, C. J., Jagadish, T., Haverland, N., Ciborowski, P., Belshan, M., Proteomic analysis of early HIV-1 nucleoprotein complexes. J. Proteome Res. 2013, 12, 559-572.
53. Ryzhova, E. V., Vos, R. M., Albright, A. V., Harrist, A. V. et al., Annexin 2: a novel human immunodeficiency virus type 1 Gag binding protein involved in replication in monocyte-derived macrophages. J. Virol. 2006, 80, 2694-2704.
54. Enrich, C., Rentero, C., deMuga, S. V., Reverter, M. et al., Annexin A6-linking Ca(2+) signaling with cholesterol transport. Biochim. Biophys. Acta 2011, 1813, 935-947.
55. Jager, S., Cimermancic, P., Gulbahce, N., Johnson, J. R. et al., Global landscape of HIV-human protein complexes. Nature 2012, 481, 365-370.
56. Chaudhuri, A., Yang, B., Gendelman, H. E., Persidsky, Y., Kanmogne, G. D., STAT1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrier. Blood 2008, 111, 2062-2072.
57. Pratt, R. D., Nichols, S., McKinney, N., Kwok, S. et al., Virologic markers of human immunodeficiency virus type 1 in cerebrospinal fluid of infected children. J. Infectious Dis. 1996, 174, 288-293.
58. Hudson, L., Liu, J., Nath, A., Jones, M. et al., Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues. J. Neurovirol. 2000, 6, 145-155.
59. Xiao, H., Neuveut, C., Tiffany, H. L., Benkirane, M. et al., Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1. Proc. Natl. Acad. Sci. USA 2000, 97, 11466-11471.
60. Kanmogne, G. D., Schall, K., Leibhart, J., Knipe, B. et al., HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis. J. Cerebral Blood Flow Metab. 2007, 27, 123-134.
61. Corasaniti, M. T., Piccirilli, S., Paoletti, A., Nistico, R. et al., Evidence that the HIV-1 coat protein gp120 causes neuronal apoptosis in the neocortex of rat via a mechanism involving CXCR4 chemokine receptor. Neurosci. Lett. 2001, 312, 67-70.
62. Jurado, A., Rahimi-Moghaddam, P., Bar-Jurado, S., Richardson, J. S. et al., Genetic markers on HIV-1 gp120 C2-V3 region associated with the expression or absence of cognitive motor complex in HIV/AIDS. J. Neuro AIDS 1999, 2, 15-28.
63. Gilbert, M., Kirihara, J., Mills, J., Enzyme-linked immunoassay for human immunodeficiency virus type 1 envelope glycoprotein 120. J. Clin. Microbiol. 1991, 29, 142-147.
64. Oh, S. K., Cruikshank, W. W., Raina, J., Blanchard, G. C. et al., Identification of HIV-1 envelope glycoprotein in the serum of AIDS and ARC patients. J. Acquir. Immune Defic. Syndr. 1992, 5, 251-256.
65. Klasse, P. J., Moore, J. P., Is there enough gp120 in the body fluids of HIV-1-infected individuals to have biologically significant effects? Virology 2004, 323, 1-8.
66. Parren, P. W., Burton, D. R., Sattentau, Q. J., HIV-1 antibody-debris or virion? Nat. Med. 1997, 3, 366-367.
67. Go, E. P., Irungu, J., Zhang, Y., Dalpathado, D. S. et al., Glycosylation site-specific analysis of HIV envelope proteins (JR-FL and CON-S) reveals major differences in glycosylation site occupancy, glycoform profiles, and antigenic epitopes' accessibility. J. Proteome Res. 2008, 7, 1660-1674.
68. Irungu, J., Go, E. P., Zhang, Y., Dalpathado, D. S. et al., Comparison of HPLC/ESI-FTICR MS versus MALDI-TOF/TOF MS for glycopeptide analysis of a highly glycosylated HIV envelope glycoprotein. J. Am. Soc. Mass Spectrom. 2008, 19, 1209-1220.
69. Sagar, M., Laeyendecker, O., Lee, S., Gamiel, J. et al., Selection of HIV variants with signature genotypic characteristics during heterosexual transmission. J. Infectious Dis. 2009, 199, 580-589.
70. Go, E. P., Hewawasam, G., Liao, H. X., Chen, H. et al., Characterization of glycosylation profiles of HIV-1 transmitted/founder envelopes by mass spectrometry. J. Virol. 2011, 85, 8270-8284.
71. Zhu, Z., Su, X., Clark, D. F., Go, E. P., Desaire, H., Characterizing O-linked glycopeptides by electron transfer dissociation: fragmentation rules and applications in data analysis. Anal. Chem. 2013, 85, 8403-8411.
72. Go, E. P., Chang, Q., Liao, H. X., Sutherland, L. L. et al., Glycosylation site-specific analysis of clade C HIV-1 envelope proteins. J. Proteome Res. 2009, 8, 4231-4242.
73. Go, E. P., Zhang, Y., Menon, S., Desaire, H., Analysis of the disulfide bond arrangement of the HIV-1 envelope protein CON-S gp140 DeltaCFI shows variability in the V1 and V2 regions. J. Proteome Res. 2011, 10, 578-591.
74. Ma, B. J., Alam, S. M., Go, E. P., Lu, X. et al., Envelope deglycosylation enhances antigenicity of HIV-1 gp41 epitopes for both broad neutralizing antibodies and their unmutated ancestor antibodies. PLoS Pathogens 2011, 7, e1002200.
75. Go, E. P., Liao, H. X., Alam, S. M., Hua, D. et al., Characterization of host-cell line specific glycosylation profiles of early transmitted/founder HIV-1 gp120 envelope proteins. J. Proteome Res. 2013, 12, 1223-1234.
76. French, M. A., Center, R. J., Wilson, K. M., Fleyfel, I. et al., Isotype-switched immunoglobulin G antibodies to HIV Gag proteins may provide alternative or additional immune responses to 'protective' human leukocyte antigen-B alleles in HIV controllers. Aids 2013, 27, 519-528.
77. Yates, N. L., Lucas, J. T., Nolen, T. L., Vandergrift, N. A. et al., Multiple HIV-1-specific IgG3 responses decline during acute HIV-1: implications for detection of incident HIV infection. Aids 2011, 25, 2089-2097.
78. Chertova, E., Bess, J. W., Jr., Crise, B. J., Sowder, I. R. et al., Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus. J. Virol. 2002, 76, 5315-5325.
79. Pelchen-Matthews, A., Kramer, B., Marsh, M., Infectious HIV-1 assembles in late endosomes in primary macrophages. J. Cell Biol. 2003, 162, 443-455.
80. Linde, M. E., Colquhoun, D. R., Ubaida Mohien, C., Kole, T. et al., The conserved set of host proteins incorporated into HIV-1 virions suggests a common egress pathway in multiple cell types. J. Proteome Res. 2013, 12, 2045-2054.
81. Misumi, S., Fuchigami, T., Takamune, N., Takahashi, I. et al., Three isoforms of cyclophilin A associated with human immunodeficiency virus type 1 were found by proteomics by using two-dimensional gel electrophoresis and matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Virol. 2002, 76, 10000-10008.
82. Mascarenhas, A. P., Musier-Forsyth, K., The capsid protein of human immunodeficiency virus: interactions of HIV-1 capsid with host protein factors. FEBS J. 2009, 276, 6118-6127.
83. Saphire, A. C., Gallay, P. A., Bark, S. J., Proteomic analysis of human immunodeficiency virus using liquid chromatography/tandem mass spectrometry effectively distinguishes specific incorporated host proteins. J. Proteome Res. 2006, 5, 530-538.
84. Yang, W., Zhou, J. Y., Chen, L., Ao, M. et al., Glycoproteomic analysis identifies human glycoproteins secreted from HIV latently infected T cells and reveals their presence in HIV+ plasma. Clin. Proteomics 2014, 11, 9.
85. Nguyen, E. V., Gharib, S. A., Crothers, K., Chow, Y. H. et al., Proteomic landscape of bronchoalveolar lavage fluid in human immunodeficiency virus infection. Am. J. Physiol. Lung Cell. Mol. Physiol. 2014, 306, L35-L42.
86. Cuevas-Cordoba, B., Santiago-Garcia, J., Saliva : a fluid of study for OMICS. Omics 2014, 18, 87-97.
87. Bora, A., Ubaida Mohien, C., Chaerkady, R., Chang, L. et al., Identification of putative biomarkers for HIV-associated neurocognitive impairment in the CSF of HIV-infected patients under cART therapy determined by mass spectrometry. J. Neurovirol. 2014, 20, 457-465.
88. Mann, M., Comparative analysis to guide quality improvements in proteomics. Nat. Methods 2009, 6, 717-719.
89. Patel, V. J., Thalassinos, K., Slade, S. E., Connolly, J. B. et al., A comparison of labeling and label-free mass spectrometry-based proteomics approaches. J. Proteome Res. 2009, 8, 3752-3759.
90. Bantscheff, M., Lemeer, S., Savitski, M. M., Kuster, B., Quantitative mass spectrometry in proteomics: critical review update from 2007 to the present. Anal. Bioanal. Chem. 2012, 404, 939-965.
91. Zhang, N., Zhang, Z., Feng, S., Wang, Q. et al., Quantitative analysis of differentially expressed saliva proteins in human immunodeficiency virus type 1 (HIV-1) infected individuals. Anal. Chim. Acta 2013, 774, 61-66.
92. Gillet, L. C., Navarro, P., Tate, S., Rost, H. et al., Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis. Mol. Cell. Proteomics 2012, 11, O111 016717.
93. Villeneuve, L. M., Stauch, K. L., Fox, H. S., Proteomic analysis of the mitochondria from embryonic and postnatal rat brains reveals response to developmental changes in energy demands. J. Proteomics 2014, 109C, 228-239.
94. Wiederin, J. L., Donahoe, R. M., Anderson, J. R., Yu, F. et al., Plasma proteomic analysis of simian immunodeficiency virus infection of rhesus macaques. J. Proteome Res. 2010, 9, 4721-4731.
95. Wiederin, J. L., Yu, F., Donahoe, R. M., Fox, H. S. et al., Changes in the plasma proteome follows chronic opiate administration in simian immunodeficiency virus infected rhesus macaques. Drug Alcohol Depend. 2012, 120, 105-112.
96. Angel, T. E., Jacobs, J. M., Spudich, S. S., Gritsenko, M. A. et al., The cerebrospinal fluid proteome in HIV infection: change associated with disease severity. Clin. Proteomics 2012, 9, 3.
97. Jensen, K., Goo, Y. A., Yahiaoui, A., Bajwa, S. et al., Identification of fatigue biomarkers in treated and treatment-naive HIV patients: preliminary results. Biol. Res. Nurs. 2013, 16, 278-287.
98. Banerjee, S., Liao, L., Russo, R., Nakamura, T. et al., Isobaric tagging-based quantification by mass spectrometry of differentially regulated proteins in synaptosomes of HIV/gp120 transgenic mice: implications for HIV-associated neurodegeneration. Exp. Neurol. 2012, 236, 298-306.
99. Burgener, A., Boutilier, J., Wachihi, C., Kimani, J. et al., Identification of differentially expressed proteins in the cervical mucosa of HIV-1-resistant sex workers. J. Proteome Res. 2008, 7, 4446-4454.